Immunization of immunosuppressed patients – Knowledge, practices and serological responsePneumococcal vaccination of renal transplant patients in immunomodulatory therapy and end-stage renal disease patients. A randomized, unblinded phase 3 clinical trial examining the immune response of 2 different combinations of pneumococcal vaccination in renal transplant patients and end-stage renal disease patients
Latest Information Update: 06 Jun 2022
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary) ; Pneumococcal vaccine (Primary)
- Indications Bacterial infections; Mycoses
- Focus Therapeutic Use
- 26 May 2022 Results assessing immunogenicity and safety of double dosage of pneumococcal vaccine published in the Vaccine
- 11 Apr 2021 Status changed from recruiting to completed.
- 11 Mar 2020 Planned End Date changed from 20 Oct 2020 to 20 Oct 2021.